Lexeo Therapeutics, Inc. (LXEO) Misses Q4 EPS by 6c

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q4 EPS of ($0.78), $0.06 worse than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• DA Davidson Reiterates Neutral Rating on Brunswick Corp (BC)
• INVO Fertility (IVF) Tops Q2 EPS by 105c